Acta Diabetologica

, Volume 56, Issue 1, pp 29–31 | Cite as

The roots of SGLT inhibition: Laurent-Guillaume de Koninck, Jean Servais Stas and Freiherr Josef von Mering

  • Viktor JörgensEmail author

SGLT inhibitors, are contemporaneously considered a “hot topic” in the field diabetology and as an introduction, it is commonplace for presentations on this topic to start with a historical retrospect on the discovery of phlorizin and its glucosuric effect. In point of fact, it was mentioned during the presentation of a major trial during the 2017 ADA Scientific Sessions, as well as in recent publications, that phlorizin was discovered by “French” chemists. The reality, however, is that phlorozin was discovered in Belgium by Belgian researchers. Furthermore, it is often cited that Josef von Mering discovered the glucosuric effect of phlorizin. Nonetheless, what is perhaps not so widely known is the fact that Freiherr Josef von Mering had already described the glucose lowering effect of phlorozin and had postulated that the action of phlorizin occurs in the kidney—a hypothesis which was latterly proven to be correct by Oscar Minkowski.


Compliance with ethical standards

Conflict of interest

The author declares that they have no competing intrest.


  1. 1.
    Bourgeois E (1936) Laurent-Guillaume De Koninck. In: Halkin LE (eds) Liber memorialis. L’Université de Liège de 1867 à 1935. Notices biographiques: II. Faculté des Sciences, Ecoles Spéciales, Faculté Technique, pp 9–18Google Scholar
  2. 2.
    Delhez R (1968) Jean-Servais Stas 1813–1891. In: Florilège des Sciences en Belgique pendant le XIXe siècle et le début du XXe. Brussel, pp 285–321Google Scholar
  3. 3.
    De Koninck LG (1835) Über das Phloridzin (Phlorrhizin) Annalen der Pharmacie. Heidelberg 15(1):75–77Google Scholar
  4. 4.
    J F (1835) Note sur une substance nouvelle nommée phloridzin par MM de Konninck (sic!) et J. S. Stas. J Chim. Méd:259Google Scholar
  5. 5.
    Phloridzin von Konnink und Stas (1835) Pharmaceutisches Central-Blatt, short announcements, Leipzig, Leopold Voss vol 1, 25 6.1835, p 398Google Scholar
  6. 6.
    Stas JS (1839) Über das phloridzin. Prakt Chem XVII 3:273–298CrossRefGoogle Scholar
  7. 7.
    Von Mering J (1886) Über künstlichen Diabetes; Centralblatt für die medizinische Wissenschaft 22:31Google Scholar
  8. 8.
    Von Mering J (1877) Über die Abzugswege des Zuckers aus der Darmhöhle. Arch Anat Physiol 1877:379–415Google Scholar
  9. 9.
    Von Mering J (1886) Über experimentellen Diabetes; Verhandlungen des V Congresses für Innere Medizin in Wiesbaden. J F Bergmann, Wiesbaden, pp 185–189Google Scholar
  10. 10.
    Von Mering J (1887) Über Diabetes mellitus; Verhandlungen des VI Congresses für Innere Medizin in Wiesbaden. J. F. Bergmann, Wiesbaden, pp 349–358Google Scholar
  11. 11.
    Minkowski O (1892) Weitere Mittheilungen über den Diabetes mellitus nach Exstirpation des Pankreas. Berliner Klin Wochenschr 29:90–93Google Scholar
  12. 12.
    Jörgens V, Minkowski O (2005) Past masters: Oskar Minkowski (1858–1931). Diabetologia 48(8):A7PubMedGoogle Scholar
  13. 13.
    Jörgens V (2016) Josef Freiherr von Mering (1849–1908). (internet) Apr 18 Diapedia 110498136 rev. No. 17.

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.EASDDüsseldorfGermany

Personalised recommendations